By activating dozens of genes that combat free radicals and toxic pollutants in cigarette smoke, a naturally produced protein called Nrf2 can stand as a stalwart defender against emphysema, a new study suggests.
The finding indicates that variations in the gene encoding Nrf2 might partly explain why some smokers get emphysema while others don’t.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.